Cargando…

New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors

[Image: see text] Synthesis of diarylmethanes, a key building block for SGLT2 inhibitors, has been developed through ketone synthesis by Friedel–Crafts acylation with TiCl(4), followed by reduction with TiCl(4)/NaBH(4). The new protocol proceeded more cleanly than the previous methods employing AlCl...

Descripción completa

Detalles Bibliográficos
Autores principales: Seki, Masahiko, Tapkir, Sandeep Ramesharao, Nadiveedhi, Maheshwara Reddy, Mulani, Shaheen Kasim, Mashima, Kazushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193421/
https://www.ncbi.nlm.nih.gov/pubmed/37214716
http://dx.doi.org/10.1021/acsomega.3c01972
_version_ 1785043833948471296
author Seki, Masahiko
Tapkir, Sandeep Ramesharao
Nadiveedhi, Maheshwara Reddy
Mulani, Shaheen Kasim
Mashima, Kazushi
author_facet Seki, Masahiko
Tapkir, Sandeep Ramesharao
Nadiveedhi, Maheshwara Reddy
Mulani, Shaheen Kasim
Mashima, Kazushi
author_sort Seki, Masahiko
collection PubMed
description [Image: see text] Synthesis of diarylmethanes, a key building block for SGLT2 inhibitors, has been developed through ketone synthesis by Friedel–Crafts acylation with TiCl(4), followed by reduction with TiCl(4)/NaBH(4). The new protocol proceeded more cleanly than the previous methods employing AlCl(3) and BF(3)·OEt(2)/Et(3)SiH to provide the diarylmethanes corresponding to canagliflozin, empagliflozin, and luseogliflozin in a highly expedient and affordable manner. In the case of a diarylmethane for the synthesis of dapagliflozin, the reduction step took place by an alternative method using InCl(3)/Al/BF(3)·OEt(2).
format Online
Article
Text
id pubmed-10193421
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101934212023-05-19 New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors Seki, Masahiko Tapkir, Sandeep Ramesharao Nadiveedhi, Maheshwara Reddy Mulani, Shaheen Kasim Mashima, Kazushi ACS Omega [Image: see text] Synthesis of diarylmethanes, a key building block for SGLT2 inhibitors, has been developed through ketone synthesis by Friedel–Crafts acylation with TiCl(4), followed by reduction with TiCl(4)/NaBH(4). The new protocol proceeded more cleanly than the previous methods employing AlCl(3) and BF(3)·OEt(2)/Et(3)SiH to provide the diarylmethanes corresponding to canagliflozin, empagliflozin, and luseogliflozin in a highly expedient and affordable manner. In the case of a diarylmethane for the synthesis of dapagliflozin, the reduction step took place by an alternative method using InCl(3)/Al/BF(3)·OEt(2). American Chemical Society 2023-05-08 /pmc/articles/PMC10193421/ /pubmed/37214716 http://dx.doi.org/10.1021/acsomega.3c01972 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Seki, Masahiko
Tapkir, Sandeep Ramesharao
Nadiveedhi, Maheshwara Reddy
Mulani, Shaheen Kasim
Mashima, Kazushi
New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors
title New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors
title_full New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors
title_fullStr New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors
title_full_unstemmed New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors
title_short New Synthesis of Diarylmethanes, Key Building Blocks for SGLT2 Inhibitors
title_sort new synthesis of diarylmethanes, key building blocks for sglt2 inhibitors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193421/
https://www.ncbi.nlm.nih.gov/pubmed/37214716
http://dx.doi.org/10.1021/acsomega.3c01972
work_keys_str_mv AT sekimasahiko newsynthesisofdiarylmethaneskeybuildingblocksforsglt2inhibitors
AT tapkirsandeepramesharao newsynthesisofdiarylmethaneskeybuildingblocksforsglt2inhibitors
AT nadiveedhimaheshwarareddy newsynthesisofdiarylmethaneskeybuildingblocksforsglt2inhibitors
AT mulanishaheenkasim newsynthesisofdiarylmethaneskeybuildingblocksforsglt2inhibitors
AT mashimakazushi newsynthesisofdiarylmethaneskeybuildingblocksforsglt2inhibitors